Segments - Rhytidectomy Market by Type (Traditional Facelift, SMAS Facelift, Deep-plane Facelift, Mid-Facelift, Mini Facelift, and Cutaneous Facelift), Area of Treatment (Mandibular, Chin, Nasal, Jaw, Injectable, and Malar), End-user (Specialty Clinics, Trauma Centers, Hospital, and Ambulatory Surgical Centers), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
The global rhytidectomy market size was around USD 2.5 Bn in 2022 and is expected to reach USD 4.1 Bn by 2031, expanding at a CAGR of 7.6% during 2023 – 2031. The growth of the market is attributed to the increased alertness of cosmetic and esthetic processes mixed with the improvement in esthetic procedures. Rising demand for therapeutic tourism, where people travel for different surgical operations, and the demand for new facial products is contributing to the market growth.
Rhytidectomy is a surgical process to give a younger look to the face, it also tightens the sagging skin, and smoothens wrinkles. Rhytidectomy or a facelift is not operated on superficial wrinkles and skin color flaws. It improves signs of aging in the face.
According to NHS, the cost to perform rhytidectomy varies from clinic to clinic which depends on the extent of the process, and one can expect anything from a few thousand pounds to USD 10,000 for a face and neck lift.
According to NCBI, rhytidectomy was relatively unknown in the early 20th century, due to the negative public perceptions of cosmetic surgery. The first facelift was done in 1901 by Eugene von Hollander, which involved excision and reapproximating of excess skin with minimal undermining.
According to the American Society of Plastic Surgeons (ASPS), rhytidectomy is among the top 5 most commonly done cosmetic surgical processes, with over 120,000 performed in 2019.
According to a study in 2015, the rhytidectomy procedure has a complication ratio of 1.8%. This analysis in 2015 does not concentrate on any particular type of facelift, it only looks at 11,300 facelifts done between 2008 and 2013, and the complexities that appeared in the particular group of patients.
According to the American Society of Plastic Surgeons (ASPS), the Society’s certified surgeons expressed that they stopped operating surgical procedures for an average of 8.1 weeks in 2020, due to the COVID-19 outbreak, or 15 percent of the year, which reflects the drop in the total number of procedures performed in the previous year.
At the time of the pandemic, 11% of women surveyed, indicated that they are further interested in non-surgical procedures or cosmetic plastic surgery since the COVID-19 outbreak and the numbers are even higher among those women who already had surgeries before. Furthermore, 35% of women who have done it at least once before, planned to do procedures more in 2021 than in 2020.
The rising adoption and popularity of facelift surgeries in females due to age-related issues and the growing population adopting facelift surgeries. As per a report from NCBI, there’s a study that tends to evaluate and compare the value of rhytidectomy in a traditional market and in an approaching market. A random sampling survey was conducted through online forums to 162 observers in the United States and 74 observers in India.
Applicants were shown pre and post-operational photos of 10 patients who go through cosmetic rhinoplasty and 2 patients who did not experience surgery. Audiences were questioned to assess the recognized changes in age, attractiveness, and in willingness to pay (WTP). There is a very much alike and genuine tendency between change in attractiveness and WTP in India and the United States.
Standard values of rhytidectomy in both India and the United States are expected a similar ratio of 2.122 compared with the ratio between both countries in the 2018 Big Mac index. The comparison of the trend in willing to pay (WTP) in India and in the United States shows that facial cosmetic surgery functions as luxury goods in both emerging and established industries.
Technological development in leading diagnostic imaging equipment is projected to propel the market growth during the forecast period. The advancement of computer-generated figures brings a brief perspective of the surgery on the patients and is expected to drive the market. The rising need for cosmetic surgeries in the male population boosts the market.
High expenses of surgery procedures, damage to the facial nerves, the inadequacy of trained hospital individuals, and high risk of infection are expected to restrain the market growth. Moreover, some post-surgery complications such as changes in the angle of ears and scarring are likely to limit the growth of the market. Facelift surgery provides both temporary and permanent results. If a patient undergoes a temporary facelift, then there are some chances for the patient to do the same surgery again which is very costly and thus can hamper the market.
The market report includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Rhytidectomy Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016 – 2021 |
Forecast Period |
2023–2031 |
Segmentation |
Type (Traditional Facelift, SMAS Facelift, Deep-plane Facelift, Mid-Facelift, Mini Facelift, and Cutaneous Facelift), Area of Treatment (Mandibular, Chin, Nasal, Jaw, Injectable, and Malar), and End-user (Specialty Clinics, Trauma Centers, Hospital, and Ambulatory Surgical Centers) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
GALDERMA; AbbVie Inc.; Merz Pharma; Johnson & Johnson Private Limited; Cutera; Millennium Surgical Corp.; and Sientra, Inc. |
Based on type, the rhytidectomy market is divided into traditional facelift, mid-facelift, SMAS facelift, deep-plane facelift, mini facelift, and cutaneous facelift. The traditional facelift segment is expected to hold a key share of the market in the coming years, as it helps to tighten the facial muscles and improve loose facial skin. The traditional facelift is used to operate frown lines, wrinkles, and other aging signs on the face. It is beneficial for patients who want to maintain their overall facial appearance.
The mid-facelift segment is anticipated to grow at a rapid pace during the forecasted period, as this type of practice needs less time to recover. It is operated on the middle third of the face. Mid-facelift helps in boosting confidence in patients as it gives younger look to their appearance.
On the basis of area of treatment, the market is divided into mandibular, chin, nasal, jaw, injectable, and malar. The chin segment is projected to register a considerable CAGR during the projection period. Chin implants are expected to use for the improvement of the projection and size of the chin that is out of proportion to the mid-face and forehead. Chin improvement surgery helps in improvising weak or sunken chin. The increasing rate of chin augmentation treatments for facial revitalization is likely to propel the market growth.
The jaw segment is anticipated to grow at a significant growth rate, owing to the extensive use of jaw surgery relevant technologies and equipment. Jaw surgery is a medical procedure used to operate jaw-related procedures and facial imbalances, dental calibration, and patients having complicated jaws.
Based on end-user, the market is divided into ambulatory surgical centers, specialty clinics, trauma centers, and hospitals. The hospital segment is anticipated to lead the market during the forecast period, due to the rising demand for facelift surgeries and also an increasing number of clinics and hospitals performing different surgeries. The majority of plastic surgeons find the convenience to do the procedures in hospitals. The continuous growth of plastic surgeries in cosmetic centers is expected to boost the market.
In terms of region, the global rhytidectomy market is divided into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The Asia Pacific is accounted for a key share of the market in 2021 and is expected to generate a large revenue share in the coming years, due to the developing infrastructure, and economic growth specifically in India and China. The market growth is further attributed to the development of the tourism industry and forming of tourism clusters.
The market in North America is anticipated to hold a significant market share, due to the convenience of technologically advanced cosmetic surgical devices and rising awareness of the latest cosmetic methods among the people in the region.
The global rhytidectomy market has been segmented on the basis of
Key players competing in the global rhytidectomy market are GALDERMA; AbbVie Inc.; Merz Pharma; Johnson & Johnson Private Limited; Cutera; Millennium Surgical Corp.; and Sientra, Inc.
These companies adopted development strategies including mergers, acquisitions, partnerships, collaboration, product launches, and production expansion to expand their consumer base worldwide. For instance,
In August 2021, on this day Merz Therapeutics, a part of the Merz Group and a leader in neurotoxins received permission to use XEOMIN for the treatment of chronic sialorrhea. Chronic sialorrhea is found in some children and adolescents, in the age group of 2 to 17 years, and weighing less than or equal to 12 kg, due to neurodevelopmental disorders on the EU level.